Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Breast (Edinburgh, Scotland)|October 10, 2007
Benefit from adjuvant taxanes and endocrine responsiveness in breast cancerMiguel Martin, John Mackey, Charles VogelInternational Journal of Clinical and Experimental Pathology|September 11, 2010
STAT3 upregulates the protein expression and transcriptional activity of β-catenin in breast cancerHanan Armanious, Pascal Gelebart, John Mackey, et al.Journal of Cell Science|May 21, 2013
Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3σZackie Aktary, Stephen Kulak, John Mackey, et al.Applied Bioinformatics|May 8, 2004
Clinically validated benchmarking of normalisation techniques for two-colour oligonucleotide spotted microarray slidesJennifer Listgarten, Kathryn Graham, Sambasivarao Damaraju, et al.BMC Cancer|September 16, 2016
Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN)Edith Pituskin, Mark Haykowsky, Margaret McNeely, et al.Human Pathology|August 17, 2010
Clinical and biological significance of GSK-3β inactivation in breast cancer-an immunohistochemical studyHanan Armanious, Jean Deschenes, Pascal Gelebart, et al.BMC Cancer|August 6, 2016
Efficacy of night-time compression for breast cancer related lymphedema (LYNC): protocol for a multi-centre, randomized controlled efficacy trialMargaret L McNeely, Kristin L Campbell, Marc Webster, et al.Clinical Breast Cancer|November 26, 2009
TRIO-012: a multicenter, multinational, randomized, double-blind phase III study of IMC-1121B plus docetaxel versus placebo plus docetaxel in previously untreated patients with HER2-negative, unresectable, locally recurrent or metastatic breast cancerJohn Mackey, Karen Gelmon, Miguel Martin, et al.Plos One|December 7, 2013
A machine learned classifier that uses gene expression data to accurately predict estrogen receptor statusMeysam Bastani, Larissa Vos, Nasimeh Asgarian, et al.Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 4, 2017
The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical TrialsDat T Tran, Ilke Akpinar, Richard Fedorak, et al.Pageof 5